{
    "ABCB11": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Kidney",
                "Source": "Nishimura",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Liver*",
                "Source": "Nishimura",
                "Relative Expression": "0.163"
            },
            {
                "Organ": "Placenta",
                "Source": "Nishimura",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Small Intestine",
                "Source": "Nishimura",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "25.999"
            },
            {
                "Organ": "Kidney",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "0.216"
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "Atorvastatin",
                "IC50 (μM)": null,
                "Ki (μM)": 9.12,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing HEK293 vesicles",
                "Reference": "Hirano, 2005"
            },
            {
                "Inhibitor": "Cerivastatin",
                "IC50 (μM)": null,
                "Ki (μM)": 11.4,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing HEK293 vesicles",
                "Reference": "Hirano, 2005"
            },
            {
                "Inhibitor": "Clofazimine",
                "IC50 (μM)": 2.3,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": 0.93,
                "Ki (μM)": null,
                "Substrate used": "Glycocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": 0.94,
                "Ki (μM)": null,
                "Substrate used": "Taurochenodeoxycholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": 8.4,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": 18.9,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Glyburide",
                "IC50 (μM)": 18.8,
                "Ki (μM)": null,
                "Substrate used": "Glycocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Glyburide",
                "IC50 (μM)": 15.8,
                "Ki (μM)": null,
                "Substrate used": "Taurochenodeoxycholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Glyburide",
                "IC50 (μM)": 11.3,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Glyburide",
                "IC50 (μM)": 14.7,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Reserpine",
                "IC50 (μM)": 2.8,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "Sf9-BSEP",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Rifampicin",
                "IC50 (μM)": 10.5,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Troglitazone",
                "IC50 (μM)": 16.0,
                "Ki (μM)": null,
                "Substrate used": "Glycocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Troglitazone",
                "IC50 (μM)": 27.6,
                "Ki (μM)": null,
                "Substrate used": "Taurochenodeoxycholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Troglitazone",
                "IC50 (μM)": 9.5,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            },
            {
                "Inhibitor": "Valinomycin",
                "IC50 (μM)": 0.7,
                "Ki (μM)": null,
                "Substrate used": "Taurocholate",
                "Cell System": "BSEP-expressing Sf9 vesicles",
                "Reference": "Kis, 2009"
            }
        ],
        "substrates": [
            {
                "Substrate": "Glycochenodeoxycholate",
                "Km (μM)": 1.7,
                "Cell System": "Sf9-BSEP",
                "Reference": "Kis, 2009"
            },
            {
                "Substrate": "Glycocholate",
                "Km (μM)": 35.5,
                "Cell System": "Sf9-BSEP",
                "Reference": "Kis, 2009"
            },
            {
                "Substrate": "Pravastatin",
                "Km (μM)": 124.0,
                "Cell System": "BSEP-expressing HEK293 vesicles",
                "Reference": "Hirano, 2005"
            },
            {
                "Substrate": "Taurochenodeoxycholate",
                "Km (μM)": 4.2,
                "Cell System": "Sf9-BSEP",
                "Reference": "Kis, 2009"
            },
            {
                "Substrate": "Taurocholate",
                "Km (μM)": 4.64,
                "Cell System": "BSEP-expressing HEK293 vesicles",
                "Reference": "Hirano, 2005"
            },
            {
                "Substrate": "Taurocholate",
                "Km (μM)": 15.0,
                "Cell System": "Sf9-BSEP",
                "Reference": "Kis, 2009"
            }
        ],
        "ddi": ""
    }
}